Esperion

Cardiometabolic Therapeutics · Prescription Drugs
$403.1MRevenue, 2025SEC ↗+21.3% a year
1Open roles
Data updated Nov 22, 2026Full reportReport a mistake

Facts

as of Nov 22, 2026

Esperion Therapeutics is a pharmaceutical company that develops and commercialises non-statin medicines to lower LDL cholesterol. Its marketed products NEXLETOL and NEXLIZET, based on bempedoic acid, treat patients with hypercholesterolemia and elevated cardiovascular risk. The company is headquartered in Ann Arbor, Michigan, United States, and works largely as a remote organisation.

It is hiring: 1 open role, 0 of them posted in the last 30 days.

Legal name
Esperion Therapeutics, Inc.
Headquarters
Ann Arbor, United States
Founded
2008
Revenue
$403.1M2025 · SEC
Open roles
1Alion job postings

As of Nov 22, 2026, Alion lists 1 open role at Esperion. Esperion is headquartered in Ann Arbor, United States. It was founded in 2008.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Esperion: 0 money records, each linked to its source.

$403.1MRevenue2025 · +21.3%
−$22.7MNet income2025 · +56.2%
Revenue by yearas filed, with the net income
2025$403.1Mnet income −$22.7M
2024$332.3Mnet income −$51.7M
2023$116.3Mnet income −$209.2M
2022$75.5Mnet income −$233.7M
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Esperion operates through 1 legal entity in 1 country.

Legal entities1 in 1 country
Esperion Therapeutics, Inc.
operator
US
Holders and shares as each register or filing states them.

Products

Products →

Esperion has 24 clinical trials on record, 1 under way. Esperion paid US doctors and teaching hospitals $562k in 2025, and $23k for research (CMS Open Payments).

221 a monthWikipedia readersEsperion Therapeutics · -59% y/y
#901,105Web rankTranco top 1M
Clinical trials
Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combinatio…
phase 4 · completed · 16 participants · Healthy Lactating Women
Aug 2023
A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily Wit…
phase 2 · completed · 31 participants · Hypercholesterolemia
Jan 2023
Bempedoic Acid Pregnancy Surveillance Program
under way · 20 participants · Pregnancy; Hyperlipidemias
Sep 2021
Wikipedia readersen.wikipedia.org
Nov 2024Oct 2026 · 221
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

Esperion: 77 research papers in five years.

Legal entity active
Esperion Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
FDA recalls
2 products since 2023 · 0 of class I
2
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring slowly: few roles were posted lately.

Sales is the largest family, 100 of open roles.

0%Remote roles0 of 1
Where the openings areshare of open roles · trend
Sales100▲
Newest roles
National Sales Director - Eastern United States
$270k – $316k per year · Remote (likely United States) · Full-Time · 12+ years exp
Benefits named in postingsshare of open roles
Health insurance1100%
Contract type
Full-Time 1
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Ann Arbor United StatesHeadquarters0
Source: office addresses in postings and company registers

Milestones

2008
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

221 a monthWikipedia readersEsperion Therapeutics · -59% y/y
#901,105Web rankTranco top 1M
Sources: the outlets named on each headline, each story once